• Most Common:
Dizziness, drowsiness, double vision, running nose, fatigue, nausea, vomiting, ataxia, abnormal vision, sore throat, abdominal pain, tremor, indigestion, abnormal gait.
• Body as a Whole: Weakness, swelling in the legs, weight increase.
• Heart: Low blood pressure
• Gastrointestinal: Diarrhea, constipation, inflammation of stomach.
♦ • Metabolic: Decreased sodium level in blood and thyroid.
• Musculoskeletal: Muscle weakness, and sprain.
• Central Nervous System: Headache, involuntary eye movement, gait, sleeplessness, tremor, nervousness, agitation, poor co-ordination, EEG abnormal, speech disorder, confusion, injury to the brain, tremor, abnormal thinking.
• Respiratory: Inflammation of nose.
• Skin: Pimple
• Potentially Fatal: Stevens-Johnson syndrome (rashes in skin and mucous membrane), toxic epidermal cell death, anaphylaxis (allergic reaction) and rapid swelling of skin.
Adult: Initial- 600 mg/day in 2 divided doses; increase the dose gradually depending on response. Maintenance: 600-1,200 mg/day, up to 2.4 g/day in adjunct therapy or refractory patients switched from other anticonvulsants.
It comes as a tablet, and a suspension is administered through mouth. It is usually taken two times per day with or without food.
• Cross-sensitivity to carbamazepine may occur.
• Avoid abrupt withdrawal.
• Caution needed for patients with history of liver or kidney disease, patients at risk of hyponatraemia (Decreased sodium level in the blood), pregnancy.
• It may make you drowsy or dizzy, or may cause vision changes.
• Do not drive a car or operate machinery while taking this medication.
Avoid alcohol consumption while taking this medication.
Store it at room temperature (25°C) and in an airtight container. Keep away from children.♦ Safety Labeling Changes Approved By FDA